The Journal of Organic Chemistry
ARTICLE
will be directed to increasing the substrate scope and improving
the catalytic efficiency of the glucuronylsynthase enzyme.
added. The aqueous titanium trichloride was added via cannula to the
stirred CMO-DHEA 3-β-D-glucuronide solution at room temperature.
The reaction instantly turned black-violet upon addition and gradually
changed to a white-gray as the reaction proceeded. After 2 h, the reaction
was deemed complete so the solution was acidified to pH 2 and dried
onto silica. The dry residue was subjected to flash chromatography
(7:2:1 ethyl acetate/methanol/water þ0.1% formic acid) to isolate
DHEA 3-β-D-glucuronide 13 (44.8 mg, 100%) as a colorless solid;
[R]20D -29 (c 0.70, MeOH), (lit.31 [R]25D -35.5 (c 1, EtOH)); Rf 0.25
(7:2:1 ethyl acetate/methanol/water). IR (NaCl): 3369 (O-H), 2938,
’ EXPERIMENTAL SECTION
17-Carboxymethoximino-dehydroepiandrosterone (CMO-
DHEA) 8.33 Pyrrolidine (600 μL, 7.19 mmol) was added to DHEA 10
(1.00 g, 3.47 mmol) dissolved in dry methanol (40 mL) at 4 °C. After 1 h
the solution had turned yellow. Carboxymethoxylamine hemihydrochloride
(800 mg, 7.32 mmol) was dissolved in a dry solution of methanol (10 mL)
and pyrrolidine (600 μL, 7.19 mmol) and transferred to the DHEA mixture
via cannula with methanol washing (5 mL). The solution immediately
cleared and was heated to reflux. The reaction was complete after 6 h. The
solvent was removed under reduced pressure, and water (100 mL) was
added to the residue. The pH was adjusted to 2 with aqueous hydrochloric
acid (2 M), and the white precipitate was extracted with ethyl acetate until
all precipitate had dissolved (5 ꢀ 150 mL with sonication required). The
organic extracts were combined, washed with water (200 mL), dried over
magnesium sulfate, and then evaporated to dryness. Cold chloroform
(5 mL) was added to the resulting yellow-white residue (1.15 g). The
white precipitate was filtered and washed with cold chloroform (2 ꢀ 3 mL)
to afford 17-carboxymethoximino-dehydroepiandrosterone 8 (1.10 g,
1
2903 (C-H), 1733 (CdO), 1636. H NMR (800 MHz, MeOD): δ
5.42 (1H, d, J = 4.9 Hz), 4.45 (1H, d, J = 7.8 Hz), 3.80 (1H, d, J = 9.7 Hz)
3.58-3.47 (2H, m), 3.38 (1H, t, J = 9.1 Hz), 3.20 (1H, t, J = 8.4 Hz),
2.48-1.43 (2H, m), 2.29 (1H, m), 2.16-2.07 (3H, m), 2.00-1.87 (3H,
m), 1.78 (1H, m), 1.74-1.52 (5H, m), 1.40-1.23 (2H, m), 1.11-1.04
(2H, m), 1.07 (3H, s), 0.90 (3H, s). 13C NMR (75 MHz, MeOD/D2O):
δ 225.5, 169.8, 142.1, 122.2, 102.1, 79.7, 77.6, 74.7, 73.5, 72.5, 52.9, 51.6,
39.5, 38.3, 37.9, 36.8, 32.7, 32.5, 31.8, 30.4, 22.7, 21.4, 19.8, 13.9, one
carbon overlapping or obscured. LRMS (-ESI) m/z: 927 ([2M - H]-,
43%), 463 ([M - H]-, 100). HRMS (-ESI) calcd for C25H35O8
([M - H]-) 463.2338, found 463.2342.
88%); mp 215-217 °C (decomp); [R]20 -36 (c 1.0, DMSO) {lit.33
’ ASSOCIATED CONTENT
D
[R]24D -37.9 (c 1, EtOH)}; Rf 0.38 (7:2:1 ethyl acetate/methanol/water).
IR (KBr): 3351 (broad, O-H), 2946, 2910, 2865, 2505 (C-H), 1680
(CdO). 1H NMR (800 MHz, d6-DMSO): δ 5.28 (1H, s), 4.61 (1H, s,
broad), 4.42 (2H, s), 3.26 (1H, obscured, m), 2.46 (1H, dd, J = 18.9, 9.0
Hz), 2.38 (1H, m), 2.16 (1H, dd, J = 12.9, 2.4 Hz), 2.09 (1H, t, J= 12.1 Hz),
1.98 (1H, m), 1.82-1.70 (3H, m), 1.67 (1H, d, J = 12.2 Hz), 1.58 (2H, m),
1.51 (1H, m), 1.42 (1H, m), 1.38-1.28 (3H, m), 1.12 (1H, m), 1.02-0.91
(2H, m), 0.96 (3H, s), 0.85 (3H, s), COOH not observed. 13C NMR (200
MHz, d6-DMSO): δ 171.3, 170.6, 141.4, 120.1, 70.0, 69.8, 53.5, 49.8, 43.5,
42.2, 36.9, 36.2, 33.8, 31.4, 30.82, 30.78, 25.7, 22.8, 20.2, 19.2, 16.8. LRMS
(þESI) m/z: 384 ([M þ Na]þ, 100%). LRMS (-ESI) m/z: 360 ([M -
H]-, 100%).; HRMS (þESI) calcd for C21H31NO4Naþ ([M þ Na]þ)
384.2151, found 384.2151.
S
Supporting Information. CIF files for the X-ray crystal
b
structures of R-D-glucuronyl fluoride 2 and CMO-DHEA
3-β-D-glucuronide 11, protein expression procedures, experimen-
tal procedures, spectroscopic data and 1H and 13C NMR spectra
for compounds 2, 8, 9, 11, 13, 14, 16 and 17. This material is
’ AUTHOR INFORMATION
Corresponding Author
*E-mail: malcolm.mcleod@anu.edu.au.
CMO-DHEA 3-β-D-Glucuronide 11. Glucuronylsynthase
(4.14 mL, 1.45 mg/mL) was added to a solution containing CMO-
DHEA 8 (20 mg, 0.055 mmol, final concentration 1.9 mM) and
R-D-glucuronyl fluoride 2 (57.5 mg, 0.270 mmol) in 100 mM sodium
phosphate buffer pH 7.5 (25 mL). The reaction was incubated at 37 °C
without agitation for 3 days and then dried onto reverse-phase silica. The
dried residue was subjected to reverse-phase flash chromatography (25%
aqueous acetonitrile þ 0.1% formic acid) to isolate CMO-DHEA 3-β-
D-glucuronide 11 (29 mg, 98%) as a colorless solid; [R]20D -62 (c 1.0,
DMSO); Rf 0.02 (7:2:1 ethyl acetate/methanol/water). IR (KBr): 3423
’ ACKNOWLEDGMENT
We thank the Australian Government Department of Health
and Ageing Anti-Doping Research Program for financial support.
’ REFERENCES
(1) (a) Lucaciu, R.; Ionescu, C. Farmacia 2005, 53, 10–19. (b)
Shipkova, M.; Wieland, E. Clin. Chim. Acta 2005, 358, 2–23. (c) Wells,
P. G.; Mackenzie, P. I.; Chowdhury, J. R.; Guillemette, C.; Gregory,
P. A.; Ishii, Y.; Hansen, A. J.; Kessler, F. K.; Kim, P. M.; Chowdhury,
N. R.; Ritter, J. K. Drug Metab. Dispos. 2004, 32, 281–290. (d) King,
C. D.; Rios, G. R.; Green, M. D.; Tephly, T. R. Curr. Drug Metab. 2000,
1, 143–161. (e) Mulder, G. J. Annu. Rev. Pharmacol. Toxicol. 1992,
32, 25–49.
1
(O-H), 2942 (C-H), 1745 (CdO). H NMR (800 MHz, D2O): δ
5.51 (1H, s), 4.59 (1H, d, J = 7.3 Hz), 4.38 (2H, s), 3.72-3.69 (2H, m),
3.52-3.50 (2H, m), 3.27 (1H, t, J = 7.1 Hz), 2.63 (1H, dd, J = 19.2, 8.3
Hz), 2.52 (1H, m), 2.47 (1H, d, J = 12.6 Hz), 2.29 (1H, t, J = 12.0 Hz),
2.10 (1H, d, J = 11.3 Hz), 2.00-1.92 (2H, m), 1.90-1.84 (2H, m),
1.71-1.60 (4H, m), 1.55 (1H, m), 1.46-1.41 (2H, m), 1.27 (1H, m),
1.10 (1H, t, J = 13.0 Hz), 1.06 (3H, s), 1.06-1.02 (1H, m), 0.95 (3H, s).
13C NMR (200 MHz, D2O): δ 178.9, 177.3, 177.2, 143.3, 123.4, 101.7,
81.0, 77.7, 77.7, 74.4, 73.3, 72.9, 55.0, 51.2, 45.6, 39.5, 38.1, 38.0, 34.9,
32.29, 32.27, 30.3, 27.8, 24.2, 21.6, 20.3, 17.7. LRMS (-ESI) m/z: 536
([M - H]-, 100%), 558 ([M - 2H þ Na]-, 30). HRMS (-ESI) calcd
for C27H38NO10 ([M - H]-) 536.2496, found 536.2495; calcd for
C27H37NO10Na ([M - 2H þ Na]-) 558.2315, found 558.2302.
DHEA 3-β-D-Glucuronide 13.31 CMO-DHEA 3-β-D-glucuro-
nide 11 (50 mg, 0.093 mmol) and ammonium acetate (96 mg, 1.2 mmol)
were purged with nitrogen, and then dioxane (0.5 mL) and aqueous acetic
acid (50%, 38 μL) were added. In a second flask, titanium trichloride (36
mg, 0.23 mmol) was purged with nitrogen before water (6 mL) was
€
(2) (a) Th€orngren, J.-O.; Oestervall, F.; Garle, M. J. Mass Spectrom.
2008, 43, 980–992. (b) Schulze, J. J.; Lundmark, J.; Garle, M.; Skilving,
I.; Ekstr€om, L.; Rane, A. J. Clin. Endocrinol. Metab. 2008, 93, 2500–2506.
(c) Van Eenoo, P.; Lootens, L.; Spaerkeer, A.; Van Thuyne, W.;
Deventer, K.; Delbeke, F. T. J. Anal. Toxicol. 2007, 31, 543–548. (d)
Avois, L.; Mangin, P.; Saugy, M. J. Pharm. Biomed. Anal. 2007,
44, 173–179. (e) Spyridaki, M.-H.; Kiousi, P.; Vonaparti, A.; Valavani,
P.; Zonaras, V.; Zahariou, M.; Sianos, E.; Tsoupras, G.; Georgakopoulos,
C. Anal. Chim. Acta 2006, 573-574, 242–249. (f) Jimꢀenez, C.; Ventura,
R.; Williams, J.; Segura, J.; de la Torre, R. Analyst 2004, 129, 449–455.
(3) (a) Kim, H.-J.; Ahn, K. C.; Ma, S. J.; Gee, S. J.; Hammock, B. D.
J. Agric. Food Chem. 2007, 55, 3750–3757. (b) Hebestreit, M.; Flenker,
U.; Buisson, C.; Andre, F.; Le Bizec, B.; Fry, H.; Lang, M.; Weigert, A. P.;
Heinrich, K.; Hird, S.; Sch€anzer, W. J. Agric. Food Chem. 2006,
1999
dx.doi.org/10.1021/jo101914s |J. Org. Chem. 2011, 76, 1992–2000